Zimmer Biomet Holdings Inc
Closed
SectorHealthcare
89.97 2.76
Overview
Share price change
24h
Min
87.54
Max
90.5
Income | 99M 239M |
|---|---|
Sales | -157M 2.1B |
P/E Sector Avg | 22.797 50.958 |
EPS | 2.09 |
Dividend yield | 1.1 |
Profit margin | 11.43 |
Employees | 17,000 |
EBITDA | 84M 538M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +7.02% upside |
Dividend yield Sector Avg | 1.10% 2.41% |
|---|---|
Next Earnings | 6 sie 2026 |
Next Dividend date | 31 lip 2026 |
Next Ex Dividend date | 25 cze 2026 |
Market Cap | -899M 17B |
|---|---|
Previous open | 87.21 |
Previous close | 89.97 |
News Sentiment
By Acuity
50%
50%
146 / 342 Ranking in Healthcare
Zimmer Biomet Holdings Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.